430 related articles for article (PubMed ID: 32712092)
1. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
[TBL] [Abstract][Full Text] [Related]
2. Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.
Somvanshi RK; Zou S; Kadhim S; Padania S; Hsu E; Kumar U
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166325. PubMed ID: 34921975
[TBL] [Abstract][Full Text] [Related]
3. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
Stankowska DL; Millar JC; Kodati B; Behera S; Chaphalkar RM; Nguyen T; Nguyen KT; Krishnamoorthy RR; Ellis DZ; Acharya S
Mol Vis; 2021; 27():37-49. PubMed ID: 33633438
[TBL] [Abstract][Full Text] [Related]
4. Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
Razali N; Agarwal R; Agarwal P; Tripathy M; Kapitonova MY; Kutty MK; Smirnov A; Khalid Z; Ismail NM
Exp Eye Res; 2016 Feb; 143():9-16. PubMed ID: 26424219
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Ismail NM
Eur J Pharmacol; 2019 May; 850():75-87. PubMed ID: 30716317
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
7. Characterization of the role of autophagy in retinal ganglion cell survival over time using a rat model of chronic ocular hypertension.
Lee SH; Shim KS; Kim CY; Park TK
Sci Rep; 2021 Mar; 11(1):5767. PubMed ID: 33707562
[TBL] [Abstract][Full Text] [Related]
8. Ligustrazine protects against chronic hypertensive glaucoma in rats by inhibiting autophagy via the PI3K-Akt/mTOR pathway.
Du HY; Wang R; Li JL; Luo H; Xie XY; Yan R; Jian YL; Cai JY
Mol Vis; 2021; 27():725-733. PubMed ID: 35035207
[TBL] [Abstract][Full Text] [Related]
9. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
[TBL] [Abstract][Full Text] [Related]
10. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
Babizhayev MA
Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
13. Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.
Lanzi C; Lucarini L; Durante M; Sgambellone S; Pini A; Catarinicchia S; Łażewska D; Kieć-Kononowicz K; Stark H; Masini E
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813468
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-induced IOP elevations are mediated by RhoA in the early but not the late fibrotic phase of open angle glaucoma.
Hill LJ; Mead B; Thomas CN; Foale S; Feinstein E; Berry M; Blanch RJ; Ahmed Z; Logan A
Mol Vis; 2018; 24():712-726. PubMed ID: 30429640
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
[TBL] [Abstract][Full Text] [Related]
16. MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma.
Li R; Jin Y; Li Q; Sun X; Zhu H; Cui H
Biomed Pharmacother; 2018 Apr; 100():1-7. PubMed ID: 29421576
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.
Yang F; Wang D; Wu L; Li Y
Drug Des Devel Ther; 2015; 9():6095-107. PubMed ID: 26604697
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of glaucoma: established and emerging pharmacology.
Dikopf MS; Vajaranant TS; Edward DP
Expert Opin Pharmacother; 2017 Jun; 18(9):885-898. PubMed ID: 28480761
[TBL] [Abstract][Full Text] [Related]
19. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
20. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.
Madeira MH; Ortin-Martinez A; Nadal-Nícolas F; Ambrósio AF; Vidal-Sanz M; Agudo-Barriuso M; Santiago AR
Sci Rep; 2016 Jun; 6():27532. PubMed ID: 27270337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
